368 episodes
- The UK government’s 10-Year Health Plan includes three core pillars: from hospital to community, from analogue to digital, and from sickness to prevention. And as the NHS looks to deliver more care closer to home, pharmacy has a major opportunity to play a bigger role in prevention and self-care.
In a new pharmaphorum podcast, Nicole Raleigh speaks with Nick Linton, head of Opella UK, a company challenging the conventions of care and defining a whole new way to think about health – for people, for communities, and for the planet.
Linton discusses why community pharmacy should be seen as a core part of the prevention agenda, and what that will take in terms of the right digital tools, data access, and the right support being in place – including what needs to happen across policy and industry.
You can listen to episode 288 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it – and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from. - Slow companion diagnostic adoption delays patient access to targeted therapies, particularly in regional and community hospital settings.
In a new pharmaphorum podcast, Nicole Raleigh caught up with Jane Li, vice president and general manager for companion diagnostics at Thermo Fisher Scientific, following ESMO 2026.
Li discusses what it takes for a companion diagnostic (CDx) to be ready on the day a targeted therapy reaches patients, and the barriers between diagnostic innovation and routine clinical use, as well as her key takeaways from the oncology congress.
You can listen to episode 287 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it – and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from. - Following ESMO 2026, pharmaphorum spoke with Kate Estep, chief product officer at Flatiron Health, a company answering oncology’s toughest questions by learning from the experience of every person with cancer.
Estep discusses Flatiron’s AI-powered oncology intelligence platform, Telescope, and how AI tools are changing the speed and precision of research decisions across markets, as well as Flatiron’s experience at ESMO last month.
You can listen to episode 286 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it – and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from. Patients not just at the table, but creating their own: In conversation with Donna Cryer
11/11/2026 | 22 mins.Artificial intelligence is now embedded in every stage of drug development, but the patients whose lives depend on those decisions are almost entirely absent from the design, governance, and oversight of these systems.
In a new pharmaphorum podcast, Nicole Raleigh speaks with Donna Cryer, founding partner and Chief Patient Officer of CryerHealth, LLC, as well as patient advocate, FDA Patient Representative, and founder of the Global Liver Institute and member of the Board of Advisors at PathAI.
Cryer discusses why patient inclusion is not the same as patient leadership, and why that distinction matters for drug development and AI governance.
You can listen to episode 285 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it – and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.- In a new episode of the pharmaphorum podcast, Nicole Raleigh invites Mati Gill, CEO of AION Labs, back as guest.
AION Labs is a venture studio built by a coalition of pharma heavyweights, tech giants, and leading investors to develop and integrate AI technologies to redefine drug discovery and development through the creation of new start-ups.
Gill discusses some great start-ups coming out of the AION Labs co-development model, what investors now expect of AI biotech companies, and the potential of AI in drug discovery and development for the good of human health.
You can listen to episode 284 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it – and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.
More Business podcasts
Trending Business podcasts
About pharmaphorum Podcast
pharmaphorum is one of the leading global channels for insight into the pharma and healthcare industry – and is essentially a group of passionate people who like asking excellent questions. Our podcasts offer a chance to pose some of these questions to the keenest minds in our industry to look at the big issues and opportunities facing pharma, biotech and healthcare today. With interviews and contributions from a host of industry experts and insiders, the pharmaphorum podcast is a must-listen for those who want insight into the future of health and medicine.
Podcast websiteListen to pharmaphorum Podcast, The Diary Of A CEO with Steven Bartlett and many other podcasts from around the world with the radio.net app

Get the free radio.net app
- Stations and podcasts to bookmark
- Stream via Wi-Fi or Bluetooth
- Supports Carplay & Android Auto
- Many other app features




































